02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Beginning January 15, 2020, new, more employer-friendly regulations determine how overtime pay is ca...
Read More >
In a significant victory for California employers who use arbitration agreements, the California Sup...
Read More >
On February 20, 2020, the Ministry of Human Resources and Social Security, the Ministry of Finance, ...
Read More >
Now that COVID-19 impacts and costs are a fact of life, what can we expect in the way of decisions r...
Read More >
On September 24, 2019, the U.S. Department of Labor ("DOL") revised the salary threshold for the Fai...
Read More >
More than thirty years ago, the Washington Supreme Court ruled defense counsel may not engage in ex ...
Read More >